More on NTRA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $320.76 |
|
|||
| Open | $318.53 | ||||
| 52 Wk High | $13.80 | ||||
| 52 Wk Low | $6.52 | ||||
| Day High | $330.92 | ||||
| Day Low | $318.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 604,769 | ||||
- Form 4 Natera, Inc. For: Aug 06 Filed by: Fesko John
- Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
- Natera partners with Angiex to monitor cancer drug trial with ctDNA test
- Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
- Form 4 Natera, Inc. For: Aug 10 Filed by: Sheena Jonathan
- Form SCHEDULE 13G/A Natera, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/
- Natera (NTRA) PT Raised to $363.50 at Piper Sandler
- Natera (NTRA) PT Raised to $350 at Stephens
- Natera (NTRA) PT Raised to $360 at Guggenheim
- Natera to supply MRD testing for Kupando skin cancer trial
Entities mentioned with NTRA
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- Cowen & Co | View Related Stories »
- 13G | View Related Stories »
- Show More...
